United Therapeutics (UTHR) Tops Q2 EPS by 82c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $538.30 --0%
Revenue Growth %: +1.5%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
MOGU, JFIN, KEQU, More
Revenue Growth %: +1.5%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
MOGU, JFIN, KEQU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.68, $0.82 better than the analyst estimate of $2.86. Revenue for the quarter came in at $362 million versus the consensus estimate of $339.97 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
